We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+21.59%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$755M
AUM Growth
-$233M
(-24%)
Cap. Flow
-$241M
Cap. Flow
% of AUM
-31.95%
Top 10 Holdings %
Top 10 Hldgs %
44.11%
Holding
104
New
30
Increased
5
Reduced
45
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$4.01M |
| 2 |
AKYA
Akoya BioSciences
AKYA
|
+$2.41M |
| 3 |
ABCM
Abcam PLC
ABCM
|
+$2.17M |
| 4 |
Alphatec Holdings
ATEC
|
+$2.07M |
| 5 |
AMN Healthcare
AMN
|
+$1.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quanterix
QTRX
|
+$22.5M |
| 2 |
Establishment Labs
ESTA
|
+$16.1M |
| 3 |
Glaukos
GKOS
|
+$15.8M |
| 4 |
Inspire Medical Systems
INSP
|
+$11.3M |
| 5 |
LivaNova
LIVN
|
+$8.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.02% |
| 2 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMDX
51
Insight Molecular Diagnostics
IMDX
$145M
| $3.13M | 0.42% |
681,251
-27,057
| -4% | -$136K |
|
|
VRAY
52
DELISTED
ViewRay, Inc.
VRAY
| $3.09M | 0.41% |
8,761,387
-451,844
| -5% | -$468K |
|
|
ABCM
53
DELISTED
Abcam PLC
ABCM
| $3.07M | 0.41% |
+125,537
| New | +$2.17M |
|
54
Schrodinger
SDGR
$1.4B
| $3.07M | 0.41% |
61,473
-144,211
| -70% | -$4.87M |
|
55
PUT
Charles River Laboratories
CRL
$13.5B
| $2.86M | 0.38% |
+13,600
| New | +$2.71M |
|
|
OLK
56
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $2.84M | 0.38% |
151,618
-242,607
| -62% | -$5.02M |
|
57
SOPHiA GENETICS
SOPH
$638M
| $2.73M | 0.36% |
609,501
-238,769
| -28% | -$1.08M |
|
|
AKYA
58
DELISTED
Akoya BioSciences
AKYA
| $2.67M | 0.35% |
+360,789
| New | +$2.41M |
|
59
PUT
Tandem Diabetes Care
TNDM
$1.63B
| $2.54M | 0.34% |
+103,500
| New | +$3.33M |
|
60
ICU Medical
ICUI
$4.55B
| $2.47M | 0.33% |
13,881
-14,243
| -51% | -$2.61M |
|
|
61
Alphatec Holdings
ATEC
$1.45B
| $2.39M | 0.32% |
+133,143
| New | +$2.07M |
|
|
62
AMN Healthcare
AMN
$1.28B
| $2.17M | 0.29% |
+19,925
| New | +$1.89M |
|
63
PUT
Integra LifeSciences
IART
$1.35B
| $2.17M | 0.29% |
52,700
-55,300
| -51% | -$2.66M |
|
|
64
CALL
Quanterix
QTRX
$124M
| $2.09M | 0.28% |
+92,900
| New | +$1.66M |
|
65
CALL
Elanco Animal Health
ELAN
$11.4B
| $2M | 0.26% |
+198,600
| New | +$1.84M |
|
|
CUTR
66
CALL
DELISTED
Cutera, Inc.
CUTR
| $1.95M | 0.26% |
+129,100
| New | +$2.45M |
|
67
CALL
Nano X Imaging
NNOX
$77.3M
| $1.81M | 0.24% |
+117,000
| New | +$1.62M |
|
68
Cooper Companies
COO
$15B
| $1.72M | 0.23% |
17,980
-87,692
| -83% | -$8.22M |
|
|
MASI
69
DELISTED
Masimo
MASI
| $1.65M | 0.22% |
+10,000
| New | +$1.74M |
|
70
PUT
DexCom
DXCM
$33.8B
| $1.59M | 0.21% |
+12,400
| New | +$1.5M |
|
|
VRAY
71
CALL
DELISTED
ViewRay, Inc.
VRAY
| $1.2M | 0.16% |
3,402,600
-3,297,000
| -49% | -$3.42M |
|
72
Evolent Health
EVH
$464M
| $1.19M | 0.16% |
39,397
-143,480
| -78% | -$4.64M |
|
73
CALL
Adaptive Biotechnologies
ADPT
$4.04B
| $1.19M | 0.16% |
+177,700
| New | +$1.32M |
|
74
PUT
SkinHealth Systems
SKIN
$91.1M
| $1.13M | 0.15% |
+135,600
| New | +$1.41M |
|
|
75
Adaptive Biotechnologies
ADPT
$4.04B
| $1.04M | 0.14% |
+155,059
| New | +$1.15M |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q2 2023 Portfolio in Review
As of Q2 2023, Pura Vida Investments held 104 positions worth $755M, down 24% from $988M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Pura Vida Investments withdrew a net $241M in Q2 2023, closing 18 positions and reducing 45 holdings. Its most notable exit was Transmedics, an estimated $4.17M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Industrials.
Against the trend, Pura Vida Investments opened a new position in Guardant Health worth $5M.
- Pura Vida Investments's largest Q2 2023 buy was Guardant Health: 139,591 shares worth $5M.
- Pura Vida Investments added most to Cutera, Inc. in Q2 2023, an estimated $819K increase.
- Pura Vida Investments's biggest Q2 2023 reduction was Quanterix, cutting an estimated $22.5M.
- Pura Vida Investments fully exited Transmedics in Q2 2023, selling an estimated $4.17M.
- Pura Vida Investments's ten largest holdings make up 44% of its $755M portfolio in Q2 2023.
- Pura Vida Investments opened 30 new positions and closed 18 in Q2 2023.
- Pura Vida Investments's portfolio value fell 24% quarter-over-quarter to $755M.
Based on Pura Vida Investments's 13F filing for Q2 2023, filed 14 Aug 2023.